Sanofi (SNY) Short-Term Debt issuances (2013 - 2021)

Sanofi has disclosed Short-Term Debt issuances across 6 years of filings, most recently posting $1.5 million for Q4 2021.

• In Q4 2021, Short-Term Debt issuances changed N/A year-over-year to $1.5 million; the TTM figure through Dec 2021 stood at -$578.9 million (changed N/A YoY), while the FY2020 annual figure was $322.0 million, up 286.69% from the prior year.
• Short-Term Debt issuances came in at $1.5 million for Q4 2021 at Sanofi, up from -$170.5 million in the prior quarter.
• In the past five years, Short-Term Debt issuances ranged from a high of $1.5 million in Q4 2021 to a low of -$191.8 million in Q4 2018.
• Average Short-Term Debt issuances over 3 years is -$120.2 million, with a median of -$170.5 million recorded in 2019.
• The largest YoY upside for Short-Term Debt issuances was 11.1% in 2019 against a maximum downside of 11.1% in 2019.
• Over 3 years, Short-Term Debt issuances stood at -$191.8 million in 2018, then gained by 11.1% to -$170.5 million in 2019, then jumped by 100.87% to $1.5 million in 2021.
• Per Business Quant data, the three most recent Short-Term Debt issuances figures were $1.5 million in Q4 2021, -$170.5 million in Q4 2019, and -$191.8 million in Q4 2018.